Care of Alzheimer’s disease in COVID-19
Recent findings suggested that people with dementia are particularly vulnerable to being infected by SARS-CoV-2. In the study “Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID‐19 pandemic, now and in the future”, international experts from 29 universities in 16 countries around the world devised strategies for the elderly and patients with dementia to receive the appropriate treatments during the pandemic. For example, the team advocated the use of “Telehealth” to ensure delivery of care. Online consultation and medical advice could be given in the terms of telemedicine. (2020 Aug 12;10.1002/alz.12143. doi: 10.1002/alz.12143. Online ahead of print.)
Anyone interested in future collaboration in this field of research is welcome to contact our key investigator Prof Vincent MOK in the Department of Medicine and Therapeutics, CUHK. Prof Mok’s research focuses on vascular cognitive impairment, post-stroke dementia and mixed dementia, cerebral small vessel disease, Parkinson’s disease and multi-modal brain and retinal imaging for stroke and cognitive impairment.